18 February 2014 -- The Regulatory Affairs Professionals Society (RAPS) will host a webcast tomorrow, 19 February, at 12:00 pm EST, examining the future of medical devices regulation in the EU. Parliament’s proposed revision of the existing regulation is nearing completion and would bring about sweeping changes.
Presenter Erik Vollebregt, a founding partner of the life sciences boutique law firm Axon, will discuss the status and possible timelines of the proposal’s adoption, the transitional regime and the biggest changes that will result.
Who:
- Erik Vollebregt, partner, Axon
What:
90-minute webcast entitled EU Medical Devices Regulation – Quo Vadis?
When:
19 February, 12:00 am–1:30 pm EST
How to Access:
Members of the working media may request access to this live RAPS webcast or to the recording by contacting Zachary Brousseau, senior manager, communications, RAPS, at zbrousseau@raps.org or +1 301 770 2920, ext. 245.
About RAPS
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with offices in Europe and Asia, and chapters and affiliates worldwide. RAPS.org
Help employers find you! Check out all the jobs and post your resume.
